Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
NurExone Secures Over C$3.18M Through Warrant Exercise
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
NurExone's ExoPTEN, Loaded With SiRNA, Demonstrates Ability to Target Injury and Inflammation Sites – New Study
NurExone Announces Further Expansion of ExoPTEN Patent Coverage
Updates From NurExone: Growth Conference Presentation and Website Relaunch
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development